ARTICLE | Company News
Meda's Dymista approved for allergic rhinitis
January 25, 2013 1:57 AM UTC
Meda AB (SSE:MEDAA) said its Dymista azelastine/fluticasone was approved under the EU's decentralized procedure to treat seasonal and perennial allergic rhinitis. Germany acted as the reference member...